Iovance Biotherapeutics Common Stock

Iovance Biotherapeutics (IOVA) currently reports a common stock of $19K as of June 2026. That compares with $14K in the prior-year period — up 35.7% year over year. Use the charts on this page to explore Iovance Biotherapeutics's common stock history and peer comparisons.

Iovance Biotherapeutics's common stock increased from $14K to $19K — a 35.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iovance Biotherapeutics reported $19K in common stock as of June 2026. That compares with $14K in the prior-year period — up 35.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $19K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iovance Biotherapeutics, and consider following IOVA for alerts when major investors trade the stock.

Iovance Biotherapeutics is classified in the Healthcare sector. On common stock, it currently shows $19K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IOVA with unrelated industries.